Nutex Health Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $875.3M | $479.9M | $247.6M | $219.3M | $331.5M |
| Gross profit | $444.3M | $196.3M | $34.8M | $15.4M | $179.3M |
| Operating income | $275.6M | $130.7M | -$31.8M | -$406.6M | $170.3M |
| Operating expenses | $168.7M | $65.6M | $66.5M | $422.0M | $9.0M |
| Cost of revenue | — | — | — | — | $14.6M |
| Cash from operations | $248.1M | $23.2M | $1.3M | $50.6M | $173.4M |
| Capital expenditure | $2.5M | $2.3M | $9.5M | $14.6M | $36.9M |
| Free cash flow | $245.6M | $20.8M | -$8.2M | $36.0M | $136.5M |
| Share repurchases | $5.0M | $0 | $0 | — | — |
| Impairments | $0 | $3.9M | $29.1M | $398.1M | $0 |
| Total assets | $918.5M | $655.3M | $398.2M | $431.8M | $394.7M |
| Total liabilities | $495.1M | $466.8M | $319.1M | $311.4M | $203.1M |
| Total debt | $43.5M | $41.4M | $42.4M | $38.3M | $89.4M |
Shares outstanding 6.9M
Annual filing data through FY ended December 31, 2025; float as of July 13, 2026.